Edwards Lifesciences (EW) Revenue Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 6.08% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 7.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.70% |
| Dec 31, 2025 | 13.26% |
| Sep 30, 2025 | 14.67% |
| Jun 30, 2025 | 11.89% |
| Mar 31, 2025 | 6.23% |
| Dec 31, 2024 | 9.43% |
| Sep 30, 2024 | 8.93% |
| Jun 30, 2024 | 7.08% |
| Mar 31, 2024 | 8.89% |
| Dec 31, 2023 | 194.58% |
| Sep 30, 2023 | -5.73% |
| Jun 30, 2023 | -6.91% |
| Mar 31, 2023 | -8.94% |
| Dec 31, 2022 | -67.67% |
| Sep 30, 2022 | 0.67% |
| Jun 30, 2022 | -0.15% |
| Mar 31, 2022 | 10.24% |
| Dec 31, 2021 | 11.58% |
| Sep 30, 2021 | 14.84% |
| Jun 30, 2021 | 48.76% |